PAHC (Phibro Animal Health) צמיחת רווחים בשנה הנוכחית

The annual percentage growth of net income per share illustrates the EPS trend, where the figure remains around 8.10. Phibro Animal Health (PAHC) is implementing ESG standards by treating wastewater and reducing livestock methane emissions. The development of antibiotic-free vaccines strengthens food security, while the geographical diversification of assets effectively mitigates the risks of trade wars and protectionism.

Phibro Animal Health is optimizing its global footprint by outsourcing the production of veterinary products and logistics to third-party contractors to reduce operating expenses. An analysis of the 12-month relative EPS growth rate allows for an assessment of net profit per share dynamics, revealing the actual efficiency of this outsourcing model and helping investors distinguish sustainable business growth from short-term market volatility.